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Summary
Sib-pair linkage analysis has been proposed for identifying genes that predispose to common diseases. We
have shown that the presence of assortative mating and multiple disease-susceptibility loci (genetic heteroge-
neity) can increase the required sample size for affected-affected sib pairs several fold over the sample size
required under random mating. We propose a new test statistic based on sib trios composed of either one
unaffected and two affected siblings or one affected and two unaffected siblings. The sample-size requirements
under assortative mating and multiple disease loci for these sib-trio statistics are much smaller, under most
conditions, than the corresponding sample sizes for sib pairs. Study designs based on data from sib trios with
one or two affected members are recommended whenever assortative mating and genetic heterogeneity are
suspected.
Introduction
Linkage analysis using affected sib pairs has been pro-
posed for identifying specific genes that predispose to
common diseases. Sib-pair methods (Penrose 1935;
Suarez et al. 1978; Blackwelder and Elston 1982,
1985; Suarez and Van Eerdewegh 1984; Amos et al.
1989) or other nonparametric methods (Weeks and
Lange 1988; Amos and Elston 1989) are appealing for
common diseases, since the mode of inheritance may
be unknown and since sibships or partial families with
one or more affected members may be easier to obtain
than extended pedigrees. However, for any proposed
linkage study of a common disorder, it is important to
take into account the possibilities of assortative mat-
ing, multiple disease-susceptibility loci, incomplete
penetrance, epistasis, and diagnostic uncertainties.
The presence of one or more of these factors may
substantially affect the power of linkage analysis
(Cavalli-Sforza and King 1986; Goldin and Gershon
1988; Ploughman and Boehnke 1989; Risch 1990).
In evaluating the power of sib-pair linkage analysis,
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we considered the t2 test statistic of Blackwelder and
Elston (1985), which represents the mean number of
marker alleles identical by descent (IBD) between the
sibs. This test statistic was shown by Blackwelder and
Elston (1985) to be more powerful than other pro-
posed test statistics, under most penetrance and preva-
lence combinations for a single disease locus with ran-
dom mating. Recently, Schaid and Nick (1990, 1991;
also see Knapp 1991) showed, also for a single disease
locus and random mating, that the power of the t2
statistic was quite close to that of the asymptotically
most powerful test.
We examined the power of the t2 statistic for sib
pairs with two affected members and for sib pairs with
one affected member, when there is assortative mat-
ing, when there are several loci that predispose to the
same disease, and when there is incomplete penetrance
or epistasis. We also developed test statistics for sib
trios with one, two, and three affected members, and
we examined their power under the same conditions
as those for sib pairs.
Assortative Mating and Observed Phenotypic
Concordance
When the probability that one member of a mated
pair has a specific phenotypic trait is dependent on
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whether the other mate has the same trait, then we say
that there is assortative mating relative to this trait.
For a dichotomous phenotype classification (x = 0 if
unaffected; and x = 1 if affected), the distribution of
phenotypes among mated pairs can be described with
the parametrization
WXy = P(x,) )(1)PRx) P(y)'
where x is the phenotype of the female mate and y is
the phenotype of male mate. For random mating, wy
-1.
The wxy are related to the prevalences of the affected
phenotype among females who have mates, vf =
P(x = 1), and among males who have mates, vm =
P(y= 1):
if = P(l,0)+P(1,1) = W1OVf(l-iVm)+WWI/Ifim;
Vm = P(0,1) + P(1,1) = WO1(l-vf)vm +W1ivfim.
In addition, there is the constraint E.YP(x, y) = 1.
Thus, the wxy have only 1 df once the sex-specific prev-
alences (for those individuals who have mates) are
determined. It is convenient to specify this df via the
concordance rate c of the trait in mates of affected
individuals:






Thus, the concordance rate c, along with if and vm,
can be used to specify uniquely the phenotype distribu-
tion in mated pairs.
It is important to note that the "affected" or "dis-
ease" phenotype is defined by the observer; there is no
way to know how it relates to the characteristics that
actually determine the selection of mating partners
in the population. There may be a "mate-selection"
phenotype, related to the same genetic locus or loci as
the disease phenotype, that is hidden to the observer
but relative to which assortative mating occurs. Thus,
the concordance rate for the disease phenotype may
not reveal the true degree of assortative mating. The
concordance rate for the disease phenotype may only
represent a lower bound for the concordance of the
full phenotype that is related to the genetic locus or loci
associated with the disease phenotype. For example,
although Palmour et al. (1991) found no evidence for
positive assortative mating between alcoholics or alco-
holics and psychiatrically ill persons in a Canadian
population, they did observe a significant (P < .002)
deviation from random mating between alcoholic
males and nonalcoholic daughters of alcoholic fathers.
The concordance rates considered in this paper are
similar to observed rates in clinical studies. Concor-
dance rates (computed in accordance with eq. [2])
ranging from 29% to 64% for overall psychiatric dis-
order (Merikangas 1982b) and from 7% to 44% for
alcoholism (Jacob and Bremer 1986) have been re-
ported. Substantially elevated concordance rates for
more narrowly defined disorders have also been ob-
served; for example, Merikangas (1982a) reported
that 24 (43%) of 56 married probands with primary
affective disorder had spouses who were also diag-
nosed with primary affective disorder.
Statistical Model for Assortative Mating
To determine the power of linkage tests under as-
sortative mating, the joint genotype distribution for
mated pairs at the loci associated with the disease phe-
notype must be determined. This genotype distribu-
tion depends, in general, on the concordance rate,
penetrance function, and prevalence of the mate-
selection phenotype. For simplicity of presentation,
we assume that these are the same for both the mate-
selection phenotype and the disease phenotype. Thus,
for the computation of the genotype distribution, we
make the following assumptions:
1. There are k autosomal disease-susceptibility loci,
which can act either independently or epistatically
to predispose to a clinically indistinguishable dis-
ease phenotype. Each of these loci is unlinked to
all the others.
2. Each of the k disease-susceptibility loci has two
alleles: a disease allele Ai and a wild-type allele ai,
i = 1,2, ... ,k. An individual's genotype at the k
loci is represented by s = (sI, S2, . . . ,Sk), where
si is the genotype at the ith locus, Si = aiai, Aiai, or
AAi.
3. The disease phenotype has a dichotomous classifi-
cation: x = 0 if unaffected, and x = 1 if affected.
4. The concordance rate, penetrance function, and
prevalence are the same for both the mate-selection
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phenotype and the disease phenotype. The pene-
trance function is denoted byf(xjs) = P(xls), where
x is the individual's phenotype and s is the individu-
al's genotype at the k disease-susceptibility loci.
5. The disease prevalence and penetrance function
are the same for both males and females.
Genotype Distribution under Assortative Mating
Under random mating, the assumption that the ge-
notype distribution is in equilibrium leads to a unique
choice for the genotype distribution: the Hardy-
Weinberg distribution. For the case of assortative mat-
ing when there is a single locus and complete dominant
or recessive expression, the equilibrium genotype dis-
tribution is easily determined (Wright 1921; Crow and
Felsenstein 1968). Other single-locus models have also
been presented (O'Donald 1960; Karlin 1968; Karlin
and Scudo 1969; Scudo and Karlin 1969; Stark 1977).
For multiple loci and for any form of the penetrance
function, we determine the equilibrium genotype dis-
tribution under assortative mating by a computational
method as follows: We start with an assortative-
mating population with an arbitrary initial genotype
distribution and then "breed" the population to pro-
duce the genotype distribution for the offspring of this
population. We then impose the same degree of as-
sortative mating on this second generation and com-
pute the genotype distribution of their offspring. This
process is continued until the genotype distribution
reaches equilibrium.
Since we must evaluate the relationship between the
phenotypes and genotypes of mated pairs, we consider
the joint phenotype and genotype distribution of
mated pairs, P(x,s;yt), where x and y are, respec-
tively, the phenotypes of the female and male mates,
and s and t are the genotypes of the female and male
mates at the k disease-susceptibility loci. The assump-
tion of assortative mating relative to the disease phe-
notype means that the joint genotype distribution for
mated pairs is dependent only on the joint phenotype
distribution. Thus, the genotypes of a mated pair con-
ditional on their phenotypes are independent; i.e.,
P(s,tlx,y) = P(slx)P(tly). Therefore,
P(x,s;y,t) = P(sjx)P(tly)P(x,y)






where w, is given by equation (1), f(xIs) = P(x Is) is
the penetrance function, and g(s) = P(s) is the geno-
type distribution for an individual. As was noted ear-
lier, the wx, have only 1 df, which can be specified via
the phenotypic concordance rate c of equation (2).
We now choose an arbitrary distribution for g(s) in
equation (3) and "breed" the population represented
by the distribution P(x,s;yt). The genotype distribu-
tion g*(u) of the offspring from the matings described
by P(x,s;yt) is given by




P(s, t) = Z P(x,s;y, t) .
xy
(5)
Since the disease-susceptibility loci are assumed to be
unlinked, the probability that a child has genotype u
conditional on the parents' genotypes s and t is
k k
P(uls,t) = UIP(uiIsi,ti) = l7sitiui,
i=l i=l
(6)
where nyiti is the usual genetic transition matrix for
two alleles at one autosomal locus (Elston and Stewart
1971). Thus, equation (4) becomes
g* (U) = [Hn7itist1P(st) .
st -i=l
(7)
To compute the genotype distribution for successive
generations, g*(.) is substituted in place ofg(*) in equa-
tion (3). The parameters wy must be recalculated,
since they depend on the disease prevalence, which is
altered by the new genotype distribution. The degree
of assortative mating is kept fixed by holding c, the
phenotypic concordance rate, constant. Equation (7)
then gives the genotype distribution for the third gen-
eration. By iteration in this manner, the genotype dis-
tributions for successive generations are obtained, and
this process is continued until the genotype frequencies
reach equilibrium. For a specified disease prevalence,
the equilibrium genotype distribution can be obtained
by selecting, through an interpolation search proce-
dure, the allele frequencies of the initial genotype dis-
tribution.
The uniqueness of the equilibrium genotype distri-
bution has been shown for some models of assortative
mating (Wright 1921; O'Donald 1960; Karlin 1968;
Lange 1976). For each specification of our model of
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assortative mating (i.e., number of disease loci, pene-
trance function, disease prevalence, and concordance
rate), the uniqueness of the equilibrium genotype dis-
tribution can be demonstrated empirically by showing
that it does not depend on the genotype distribution
chosen for the first generation.
Test Statistics for Sib Pairs
In examining the power of sib pairs and sib trios to
detect linkage, we make the following assumptions,
in addition to those assumptions made in the model of
assortative mating:
1. There is a polymorphic marker locus that is fully
informative in each nuclear family in the study
sample.
2. There is complete ascertainment: the probability
that any sibship with at least one affected member
will be included in the study sample is independent
of the number of affected sibs.
We wish to test the hypothesis that one of the disease-
susceptibility loci (the first of the k loci) is linked
to the marker locus with recombination frequency
0 < /2.
Since it is assumed that each family is fully informa-
tive at the marker locus (i.e., the father has genotype
Fl /F2, and the mother has genotype Ml /M2), the
distribution of marker alleles IBD for sib pairs can be
calculated from the conditional probability of a child
having marker genotype m (m = Fl/Ml, F1/M2,
F2/Ml, or F2/M2) and disease status x, given the
parents' genotypes s and t at the disease-susceptibility
loci. This probability is given by
P(x,mjs,t) = E P(xlu)P(mIui,si,ti)P(uls,t), (8)
where u takes on all the child's possible genotypes at
the disease-susceptibility loci, and ul, si, and t1 repre-
sent genotypes at the first disease-susceptibility locus.
The probability P(uls,t) is given by equation (6). In
a similar manner, Vsltlulm = P(mnluj,si,ti) can be ex-
pressed in terms of the recombination frequency 0 by
using the genetic transition matrix for two linked au-
tosomal loci (Elston and Stewart 1971). Thus, equa-
tion (8) becomes
k
P(x,mls,t) = Zf(xIu)WSit1UllRslt5u1 - (9)
U s=1
Under the null hypothesis Ho of no linkage between
the marker locus and any of the k disease loci, the
probabilities of observing either 0, 1, or 2 alleles IBD
between two sibs are, respectively, Poo = 1/4, Pol =
1/2, and P02 = 1/4. Under the alternative hypothesis Hi
of linkage between the marker locus and the first of
the k disease loci, the probability pj of observingj =
0, 1, or 2 alleles IBD between two sibs can be com-
puted using equation (9) and the joint distribution
P(s,t) of the parents' genotypes that is given by equa-
tion (5). For a sib pair with disease status (x,y),
pi Z:ZZ P(xmIst)P(y,m'Is,t)P(s,t),
s t mm'
3 j alleles IBD
where the sum over m and m' is restricted to the
marker-locus genotypes that give exactlyj alleles IBD;
the constant of proportionality is determined by the
constraint Po + Pi + P2 = 1.
Ifn affected-affected (1,1) sib pairs are observed and
no, n1, n2 are the numbers of pairs with, respectively,
0, 1, 2 marker alleles IBD, then (no~ni,n-2) trinomial
(n; PO,PlP2). The test statistic Til = bopo + bip6
+ b2P2, where Pj5 = nj/n and bo = 0, bi = 1, and b2
= 2, represents the mean number of marker alleles
IBD. We choose to use the notation T1, where the
subscript denotes the (1,1) disease status of the pair,
rather than the t2 notation of Blackwelder and Elston
(1985), to differentiate this statistic from the corres-
ponding statistic To, for unaffected-affected (0,1) sib
pairs, which we also examine.
Test Statistics for Sib Trios
We consider test statistics for each of the sib trios
with one or more affected members: (0,0,1), (0,1,1),
and (1,1,1) trios. For each trio, the test statistic is
based on the joint IBD distribution produced by all the
possible unique combinations of marker alleles IBD in
pairwise comparisons among the three sibs.
For sib trios with one or two affected members, the
joint IBD distribution has seven possible states (table
1A). For trios consisting of three affected sibs, there
are four unique states (table 1B).
We denote the probability of observing these IBD
states bypi, withj = 1 ,2, ... ,7, for (O ,0,1) or (0,1,l1)
trios, andj = 1,2,3,4 for (1 ,1,1) trios. The probabili-
ties poj for these states under the null hypothesis Ho of
no linkage are given in table 1. Under the hypothesis
HI of linkage, the probabilities of the IBD states can
be computed by enumerating all the possible arrange-
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Table I
Possible Combinations of Marker Alleles IBD in Sib Trios
A. Trios with One or Two Affected Members: Trio Disease Status (x,y1,y2) = (1,0,0) or (x,y1,y2)
= (0,1,1)
MARKERS IBD BETWEEN PAIRS
STATE PROBABILITY
j (x,yl) (x,y2) (YI,y2) UNDER Ho: poj b
1 ....... 2 2 2 1/16 0
2 ....... 2 1 1 1/4 0
3 ....... 2 0 0 1/8 0
4 . ....... 1 0 1/8 0
5 ........... 0 1 1/4 1
6 . ....... 1 2 1/8 1
7 ....... 0 0 2 1/16 2
B. Trios with Three Affected Members: Trio Disease Status (x1,X2,X3) = (1,1,1)
MARKERS IBD BETWEEN PAIRS
STATE PROBABILITY
j (X1,x2) (X1,X3) (X2,X3) UNDER Ho: Poj bja
1 ....... 2 2 2 1/16 2
2 ....... 2 1 1 3/8 1
3 ....... 2 0 0 3/16 0
4 ....... 1 1 0 3/8 0
a The test statistic for the trio is given by A, bjij.
ments of marker alleles for each member of the trio
with disease status (x,y,z):
P1 0 ZZ Z P(x,m Is, t)P(y,m'Is,t)P(z,m"Is, t)P(s,t).
s t mm'm"
3 statej observed
If n trios each with disease status (0,1,1) are ob-
served, and n ,n2, . .. ,n7 are the numbers of trios for
the seven possible IBD states, then (n1,n2, . . . ,n7) -
multinomial(n; pl ,P2 ... ,p7). Following the form of
the test statistic for sib pairs, we construct a test statis-
tic for trios that is a linear combination of the estima-
tors Pj = nj/fIn:
7
To = E bjf51.
j=1
The b1 are chosen to optimize the power of the test
statistic. By the Neyman-Pearson Lemma (Knapp
1991), the most powerful test for a specified linkage
hypothesis Hi (i.e., specified number of disease loci,
recombination frequency, penetrance function, dis-
ease prevalence, and degree of assortative mating) is
based on the ratio
PHl(nl,n2,. . . n7) 7 p_ nj
PH0(nln2, . . .n7) j=1 p
Taking the logarithm and dividing by n gives
(10)T = -fj=
j-1 j=i P
for the statistic that gives the most powerful test.
The optimal coefficients bj* vary only moderately
with different linkage hypotheses; for example, the
bj" for a dominant penetrance function are approxi-
mately the same as those for a recessive penetrance
function. The selected values for the bj are given in
table lA; this set of values gives the minimum, or near
minimum, required sample size for a wide range of
linkage hypotheses.
The statistic Too, for (0,0,1) trios is identical in form
to Toll. Indeed, since both statistics have identical
properties under the null hypothesis of no linkage, the
statistics could be combined (by simply combining the
observed numbers of IBD states: nl,n2, . . . ,n7) for
the purpose of testing the null hypothesis. However,
while the probabilities pj are the same for both trios
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under the null hypothesis, they are different under the
hypothesis of linkage. Thus, sample-size calculations
for the two trios give different results, and so we con-
sider them separately.
The statistic T11i for (1,1,1) trios is constructed in
a similar manner:
4
Till = Z bjpj,
j=1
with bj, as given in table 1B, chosen to give the mini-
mum, or near minimum, required sample size for a
range of linkage hypotheses, on the basis of compari-
son with the statistic for the Neyman-Pearson most
powerful test.
Calculation of Required Sample Size
The mean and variance of the test statistics T11, To,,
Ton1, Too)1 and Ti11 are p= jbap1, and a2 = 42/n,
respectively, where
2 = b2p/(1 - pj) - Z bibypipj
With a normal approximation, the required sample
size n for power (1 - l) and significance level a (one-
sided) is given by
)2
Z-aco + Z1 -P1)
\ o- I1
where io and 4o are computed under the null hypothe-
sis Ho of no linkage, gI and C, are computed under
the hypothesis Hi of linkage, and Zi-a is the (1 - a)th
quantile of the standard normal distribution.
Penetrance Functions
We first consider sample-size requirements for pene-
trance functions representing incomplete dominant
expression. For these cases, when considering multiple
disease loci, we assume that each of the disease-
susceptibility loci acts independently to predispose to
the disease phenotype. Table 2A gives the penetrance
function for two loci acting independently, each with
dominant expression and penetrance of .8.
To represent the possibility of sporadic cases, we set
the penetrance for wild-type homozygotes to a positive
value. Table 2B represents the situation in which spo-
Table 2
Penetrance Functions for Two
Disease-Susceptibility Loci





GENOTYPE a2a2 A2a2 A2A2
a1ai .......... 0 .8 .8
Ala1 .......... .8 .96 .96
A1A ........... .8 .96 .96





GENOTYPE a2a2 A2a2 A2A2
alai .......... .0169 .8034 .8034
A2a2 .......... .8034 .9607 .9607
A1Al .......... .8034 .9607 .9607





GENOTYPE a2a2 A2a2 A2A2
alai .......... 0 0 .8
A1a1 .......... 0 0 .8
AlA1 .......... .8 .8 .96




GENOTYPE a2a2 A2a2 A2A2
alai ............ 0 0 0
A1A1 .......... 0 .8 .8
AlAl ............ 0 .8 .8
a The penetrance function represents the case in which sporadic
events and two disease-susceptibility loci, each with dominant ex-
pression and penetrance . 8, are considered as three independent and
equal causes of disease when the total disease prevalence is .05.
radic events and two disease-susceptibility loci, each
with dominant expression and penetrance of .8, are
considered as three independent and equal causes of
disease when the total disease prevalence is .05. Table
2C gives a penetrance function for two loci acting
independently, each with recessive expression, and ta-
ble 2D represents a penetrance function for two loci
acting epistatically.
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Results
Tables 3-7 give, for sib pairs and sib trios, the sam-
ple sizes, based on the corresponding test statistic T11,
To1, T111, Ton, or Too, that are needed to detect link-
age between a disease-susceptibility locus and a single
marker locus. These tables show the required sample
size for a one-sided significance level of a = .001
(roughly equivalent to a lod score of 3) and power
(1 - 1) = .90. Tables 3-7 are derived using a recombi-
nation frequency 0 = .02 between the first disease
locus and the marker locus and a disease prevalence
of .05. Over the range of disease prevalence from .01
to .20, the sample-size requirements (data not shown)
are fairly stable, and our findings about the relative
power of the test statistics hold for this range of preva-
lence.
Tables 3-7 show the required sample sizes when
mating is random and for varying degrees of assorta-
tive mating. In table 3, required sample sizes are given
for one, two, and four disease loci, each with domi-
nant expression. The penetrance function for the case
of two disease loci is given in table 2A.
A situation in which sporadic cases of disease occur
is illustrated in table 4 (penetrance function is given
in table 2B). Table S gives sample-size requirements
for different penetrance values when there are two
disease-susceptibility loci acting independently, each
with dominant expression. Table 6 gives an example
of recessive expression (penetrance function is given
in table 2C). An example of epistasis between two
disease loci is shown in table 7 (penetrance function
is given in table 2D).
Discussion
Assortative Mating
There are two ways in which assortative mating
decreases the power of linkage tests based on affected
siblings only: First, because affected-affected matings
are more likely under assortative mating, there are
Table 3
Required Sample Sizes, by Number of Disease Loci, for Loci Acting
Independently with Incomplete Dominant Expressiona
REQUIRED SAMPLE SIZEC
No. OF Assortative Mating Concordance Rate c
DISEASE LOCI AND Random
PAIR OR TRIOb Mating .25 .50 .75
1:
(1,1) .............. 52 100 243 715
(1,1,1) .............. 22 58 172 559
(0,1,1) .............. 28 38 60 116
(0,0,1) .............. 45 49 55 68
(0,1) .............. 101 120 159 249
2:
(1,1) .............. 222 417 1,036 3,576
(1,1,1) .............. 92 221 668 2,604
(0,1,1) .............. 115 148 218 375
(0,0,1) .............. 181 185 194 210
(0,1) .............. 417 472 582 816
4:
(1,1). ............... 903 1,684 4,262 16,166
(1,1,1) ............... 360 850 2,613 11,264
(0,1,1) ............... 451 573 820 1,353
(0,0,1) ............... 707 711 718 729
(0,1) ............... 1,675 1,863 2,226 2,975
a Penetrance function for one disease locus is f(AIA1) = f(Aia1) = .8 and f(aiai) = 0. Penetrance
function for two loci is given in table 2A. Penetrance function for four loci is computed assuming four
dominant loci acting independently each with penetrance .8. Disease prevalence is .05. Recombination
frequency 0 = .02 between first disease locus and marker locus.
b Pair or trio is that on which the test statistic is based.
c For a = .001 (one-sided) and power (1 - i) = .90.
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Table 4
Required Sample Sizes for Two Disease Loci Acting Independently with
Incomplete Dominant Expression and Sporadic Cases'
REQUIRED SAMPLE SIZEC
Random Assortative Mating Concordance Rates c
PMR OR TRIOb Mating .25 .50 .75
(1,1)............... 251 375 646 1,204
(1,1,1) .............. 95 171 348 735
(0,1,1) .............. 133 156 195 255
(0,0,1) .............. 990 1,149 1,447 1,964
(0,1) .............. 1,407 1,628 2,030 2,704
a Sporadic events and the two disease loci are three independent and equal causes of disease. Penetrance
function is given in table 2B. Disease prevalence is .05. Recombination frequency 0 = .02 between first
disease locus and marker locus
b On which test statistic is based.
c For a = .001 (one-sided) and power (1 - 1) = .90.
Table 5
Required Sample Sizes, by Penetrnce, for Two Disease Loci Acting
Independently with Incomplete Dominant Expression'
REQUIRED SAMPLE SIZEC
PENETRANCE AND Random
Assortative Mating Concordance Rate c
PAIR OR TRIOb Mating .25 .50 .75
.3:
(1,1) .............. 330 401 521 695
(1,1,1) .............. 167 218 307 440
(0,1,1) .............. 489 565 687 853
(0,0,1) .............. 4,219 4,409 4,696 5,062
(0,1) .............. 6,860 7,281 7,927 8,766
.5:
(1,1) .............. 258 373 624 1,145
(1,1,1) .............. 117 197 382 790
(0,1,1) .............. 257 321 441 646
(0,0,1) .............. 966 1,020 1,110 1,244
(0,1) .............. 1,773 1,957 2,278 2,790
.7:
(1,1) .............. 230 397 864 2,367
(1,1,1) .............. 98 210 551 1,719
(0,1,1) .............. 150 194 284 474
(0,0,1) .............. 307 320 343 382
(0,1) .............. 651 736 900 1,221
.9:
(1,1) .............. 216 440 1,248 5,531
(1,1,1) .............. 88 234 807 3,952
(0,1,1) .............. 87 110 157 266
(0,0,1) .............. 107 108 109 111
(0,1) ............... 272 305 371 518
a Penetrance function is computed assuming two dominant loci acting independently, each with pene-
trance as given. Disease prevalence is .05. Recombination frequency 0 = .02 between first disease locus
and marker locus.
b Pair or trio is that on which test statistic is based.
c For a = .001 (one-sided) and power (1 -1) = .90.
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Table 6




Assortative Mating Concordance Rates c
Pair or Triob Mating .25 .50 .75
(1,1). ................ 111 178 324 643
(1,1,1) ................ 73 182 467 1,158
(0,1,1) ................ 90 105 131 176
(0,0,1) ................ 353 361 371 382
(0,1) ................ 618 656 716 802
a Penetrance function is given in table 2C. Disease prevalence is .05. Recombination frequency 0 =
.02 between first disease locus and marker locus.
b On which test statistic is based.
c For a = .001 (one-sided) and power (1 -I) = .90.
more families in which the mother and the father each
carry a disease-susceptibility allele. Two children of
such a mating can both be affected and yet not share
the same (by descent) disease allele. Clearly, this re-
duces the power of tests based on the number of
marker alleles shared among affected sibs.
Second, assortative mating causes an increase in the
proportion of individuals with two or more disease
alleles. For example, a single disease locus with domi-
nant expression, penetrance of .8, and disease preva-
lence of .05 under random mating results in a popula-
tion with .0010 of individuals homozygous for the
disease allele. Under the same conditions, assortative
mating with a concordance rate c = .5 gives a .0083
proportion of homozygotes, an eightfold increase.
In the case of two disease loci each with dominant
expression and the penetrance function of table 2A
and with disease prevalence of .05, random mating
gives a proportion of .0015 for individuals with two
or more disease alleles. Under assortative mating this
proportion becomes .0121, also an eightfold increase.
This increase, under assortative mating, in the propor-
tion of mothers and fathers with multiple disease al-
leles also leads to an increased likelihood of different
(by descent) disease alleles among affected siblings and
to a concomitant loss of power for test statistics based
on affected sibs only.
Required sample sizes for test statistics based on
only affected sibs increase quite rapidly with increas-
ing degrees of assortative mating. For the conditions
of table 3, assortative mating with a phenotypic con-
cordance rate c = .75 increases the required sample
size for (1,1) sib pairs to roughly 16-fold over the
required sample size under random mating. The re-
Table 7
Required Sample Sizes for Two Disease Loci with Epistasisa
REQUIRED SAMPLE SIZEC
Random Assortative Mating Concordance Rate c
PAIR OR TRIOb Mating .25 .50 .75
(1,1).1............... 15 180 334 705
(1,1,1) ............... 69 136 301 716
(0,1,1) ............... 97 118 158 232
(0,0,1) ............... 362 366 374 388
(0,1) ............... 650 691 764 894
a Penetrance function is given in table 2D. Disease prevalence is .05. Recombination frequency 0 =
.02 between first disease locus and marker locus.
b On which test statistic is based.
c For a = .001 (one-sided) and power (1 - I) = .90.
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quired sample size for (1,1,1) sib trios increases by
over 25-fold. But required sample sizes for pairs and
trios composed of both affected and unaffected sibs
change to a much lesser degree, by factors of 4 or less.
As the number of disease loci increases (table 3), the
required sample size increases for all types of sib pairs
and trios. However, with higher degrees of assortative
mating, the greater the difference between statistics
based on affected sibs and those based on affected and
unaffected sibs. For (1,1) pairs and (1,1,1) trios, the
combined effect of assortative mating and multiple
disease loci is greater than a multiplicative effect; for
(0,1,1), (0,0,1), and (0,1) sibships, the combined
effect of assortative mating and multiple disease loci
is less than multiplicative.
For the conditions of table 3, the power of (0,1,1)
trios is just a little better than that of twice as many
(0,1) pairs. Thus, it appears that the greater power of
(0,1,1) trios may be simply due to the fact that each
(0,1,1) trio is composed of two (0,1) pairs and one
(1,1) pair. However, when there is the possibility of
sporadic disease (table 4), (0,1,1) trios are superior to
twice as many independent (0,1) pairs plus an equal
number of independent (1,1) pairs, even under ran-
dom mating.
Sporadic Disease
Under the conditions of table 3, the test statistic
based on (0,0,1) trios has the smallest required sample
sizes for large degrees of assortative mating. But this
assumes that there are no sporadic cases of disease. If
sporadic cases of disease can occur, then the power of
the statistic for (0,0,1) trios is dramatically lower (ta-
ble 4). The statistics based on (1,1), (1,1,1), and
(0,1,1) sibships are, however, quite robust with re-
spect to the occurrence of sporadic cases. This is ex-
pected, since, with cases occurring sporadically, many
of the (0,0,1) trios have the affected member being
a sporadic case; on the other hand, a much smaller
proportion of sibships with two or more affected mem-
bers contain sporadic cases.
A close comparison oftable 4 and the corresponding
entries of table 3 for two loci reveals an apparent
anomaly: Under assortative mating, the sample-size
requirements for (1,1) and (1,1,1) sibships are less
when there are sporadic cases than when there are no
sporadic cases. This is due to different joint genotype
distributions for parents in the two situations. With
assortative mating, many families with affected chil-
dren will have parents who are both affected. But
when sporadic disease is possible, one member of an
affected-affected mating will sometimes be a sporadic
case. Hence, for the same degree of assortative mating,
there will be more families in which only one disease
allele is segregating when there are sporadic cases than
when there are no sporadic cases. Since test statistics
based on affected sibs are more powerful when only
one disease allele is present in each family, the required
sample sizes under assortative mating for these statis-
tics are smaller when there is sporadic disease than
when there is no sporadic disease.
Epistasis and Recessive Expression
The required sample sizes for the test statistics based
on (1,1) pairs, (1,1,1) trios, and (0,1,1) trios in the
case of recessive expression or epistasis (tables 6 and
7) are less than the corresponding sample sizes for
dominant expression (table 3). Thus, for these test
statistics, multiple disease loci acting independently
with dominant expression are a greater impediment to
detecting linkage than are loci with recessive expres-
sion or loci acting epistatically.
Penetrance and the Selection of Test Statistics
For high penetrances, high degrees of assortative
mating, and no sporadic disease (table 5), the Too,
statistic for (0,0,1) trios is the most powerful. But
when the penetrance is about . 6 or less, the Too, statis-
tic performs poorly. In comparison, the To01 statistic
for (0,1,1) trios is powerful at low and high pene-
trances. At penetrances greater than or equal to .5, the
To01 statistic is more powerful than the T11 statistic
for (1,1) pairs; however, for penetrances less than or
equal to .3, T11 is superior to To, .
The optimal coefficients bj* (eq. [10]) for the test
statistic for (0,1,1) trios vary for different penetrance
functions. The bj coefficients for To01 are specifically
chosen to give optimal, or near optimal, power for
penetrances greater than or equal to .5, for disease loci
with dominant expression. The lower power of the
To,, statistic relative to the T11 statistic at low pene-
trances is therefore not surprising. However, since
(0,1,1) trios contain a (1,1) pair, for a specified linkage
hypothesis (i.e., specified penetrance function, etc.),
it is always possible to construct a test statistic for
(0,1,1) trios that has power greater than or equal to
the power of any statistic for (1,1) pairs. But when the
penetrance is low, the unaffected member of the trio
contains very little information, and optimizing the
statistic for (0,1,1) trios under this condition gives
only slight improvement in power over the statistic for
(1,1) pairs. Thus, when the penetrance is unknown,
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it is a better strategy to use the bj that we have chosen,
which are optimal for penetrances greater than or
equal to .5, for analyzing data from (0,1,1) trios. The
(1,1) pairs contained in these trios can then, of course,
also be evaluated using the T1l statistic.
In contrast to the case of (0,1,1) and (0,0,1) trios,
the optimal coefficients bj* for the test statistics for
(1,1) and (0,1) pairs and for (1,1,1) trios do not vary
with the value of the penetrance, when linkage hy-
potheses with disease loci with dominant expression
are considered. For the models represented in tables
3-5, the sample size requirements of the Til, To,, and
Ti i l statistics are within 1% of the requirements of the
corresponding Neyman-Pearson most powerful tests.
Schaid and Nick (1990, 1991) showed that, for
dominant expression, the power of Til was very close
to optimal for one disease locus, with or without spo-
radic cases, and random mating. Our results show
that for TlI, along with To, and Till, this is also true
for multiple disease loci with dominant expression,
with or without sporadic cases, and assortative
mating.
The power of the test statistics T,1, To,, T11, To1l,
and Too, are farther from their optimal levels when
recessive and epistatic penetrance functions are con-
sidered. However, the sample-size requirements are
lower in these cases than they are for dominant pene-
trance functions. Thus, it is a better strategy, when
the penetrance function is unknown, to use statistics
optimized for the dominant case.
Coincidentally, although the bj coefficients for Ti1I
were chosen on the basis of comparison with the
Neyman-Pearson most powerful test, with this choice
of bj, Till + 2 is identical to the Green and Woodrow
(1977) statistic for three affected sibs.
Another test statistic for (0,1,1) trios has been con-
sidered elsewhere. Suarez et al. (1982) examined the
power of a statistic for (0,1,1) trios that was derived
from a general scoring method that Alter and Quevedo
(1979) used for families with multiple affected mem-




Suarez et al. (1982) found that the power of this test
statistic was less than that of a statistic for (1,1 ) pairs.
However, the relative inefficiency of the Z statistic
is due to its specific configuration rather than to an
inherent lack of power in (0,1,1) trios.
Mate-Selection and Disease Phenotypes
The distinction between the mate-selection pheno-
type and the disease phenotype is important, since,
in general, the penetrance functions and concordance
rates for the two phenotypes will be different. Our
methodology can easily be adjusted to compute the
required sample size when the mate-selection pheno-
type and the disease phenotype have different pene-
trance functions and concordance rates. In this case,
the concordance rate, penetrance function, and preva-
lence used for computing the genotype distribution
under assortative mating would represent the mate-
selection phenotype. The penetrance function repre-
senting the disease phenotype would then be used for
the computation of the probability distributions of the
test statistics for linkage (eq. [9]).
Conclusion
Genetic heterogeneity and assortative mating, fea-
tures of many important common disorders, may
make it difficult to collect, for any single disorder, a
sample of affected sib pairs that is adequate to detect
linkage of disease-susceptibility loci to marker loci. In
this setting, collection of data from sib trios with one
or two affected individuals may provide the basis for
successful detection of linkage. Even under conditions
of random mating, the additional effort to collect data
for sib trios may be worthwhile.
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